Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
Monsanto Forest Park Monsanto Forest Park Monsanto Forest Park () is a municipal protected forest in Lisbon, Portugal, the largest green patch in the city, with almost 1000 ha (10 km2). It offers a well diversified tree-covered area to the Portuguese capital. A large number of species were introduced in the Monsanto Hills ("Serra de Monsanto") during the reforesting period. Due to climate and geological characteristics, they created a very interesting ecosystems in the urban patch of Lisbon (and surrounding municipalities). The Ecological Park of Lisbon, located at Monsanto Forest Park, is a meeting point for a new contact with the environment, right